Saxagliptin, also known by the brand name Onglyza, is a popular drug used to help manage type 2 diabetes. It was co-developed in 2007 by Bristol-Myers Squibb and AstraZeneca. After an article published in 2016, the FDA added a warning for consumers about the increased risk of heart failure caused by taking Saxagliptin. What is…